Altered galectin-3 distribution and migratory function in the pre-diabetic non-obese diabetic mouse thymus

Front Endocrinol (Lausanne). 2024 Oct 17:15:1200935. doi: 10.3389/fendo.2024.1200935. eCollection 2024.

Abstract

Galectin-3 is an endogenous lectin which binds mainly to β-galactosides on the cell surface and extracellular matrix (ECM) glycoproteins. In the thymus, this lectin is constitutively expressed, being involved in thymocyte adhesion, migration, and death. Galectin-3 has been related to type 1 diabetes, an autoimmune disease characterized by pancreatic β-cell destruction mediated by autoreactive T lymphocytes. Non-obese diabetic (NOD) mice represent a suitable model to study type 1 diabetes, as they develop the disease like humans. We previously described important thymic alterations in these animals such as the development of giant perivascular spaces (PVS), characterized by the retention of T and B cells, intermingled with an ECM network, and associated with a defect in the expression of the fibronectin receptor VLA-5 and reduced sphingosine-1-phosphate receptor expression on developing thymocytes. In order to investigate galectin-3 expression in thymic microenvironmental cells and verify its interaction with cells and ECM molecules in PVS, we performed immunofluorescence following colocalization analysis in the thymic parenchyma of pre-diabetic NOD mice by confocal microscopy. In addition, thymocyte migration assays were performed to evaluate the effect of galectin-3 on NOD thymocyte migration. Herein, we showed a significant enhancement of colocalization with cortical and medullary thymic epithelial cells in NOD mice, as compared to controls. In the giant PVS of these animals, we observed a heterogeneous distribution of galectin-3, predominantly found in clusters of B lymphocytes and dendritic cells. Functionally, NOD thymocyte migratory response towards galectin-3 was impaired and a similar decrease was seen in transendothelial thymocyte migration. Taken together, our data provide the histological and functional background for a potential defective thymocyte migration involving galectin-3, thus placing this molecule as a further player in the intrathymic disturbances observed in pre-diabetic NOD mice.

Keywords: NOD mice; extracellular matrix; galectin-3; thymocyte migration; thymus; type 1 diabetes.

MeSH terms

  • Animals
  • Cell Movement*
  • Diabetes Mellitus, Type 1 / metabolism
  • Diabetes Mellitus, Type 1 / pathology
  • Female
  • Galectin 3* / metabolism
  • Mice
  • Mice, Inbred NOD*
  • Prediabetic State / metabolism
  • Prediabetic State / pathology
  • Thymocytes / metabolism
  • Thymus Gland* / metabolism
  • Thymus Gland* / pathology

Substances

  • Galectin 3
  • Lgals3 protein, mouse

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was supported by grants from – Oswaldo Cruz Foundation intramural funding – (DV-V Grant: 403462/2008-8); Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) – (DV-V Grants: 484235/07-9 and 311242/2013-8); Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ) – (DV-V Grant: E-26/111.373/2013). The work was also partially funded by a grant from MercoSur through the Fund for Structural Convergence (FOCEM) - (WS Grant: 03/2011). It was developed in the framework of the National Institute of Science and Technology on Neuroimmunomodulation (INCT-NIM- CNPq) – (WS Grant: 465489/2014-1); Rio de Janeiro Research Network on Neuroinflammation (Faperj) – (WS Grant: E-26/010.002418/2019), and INOVA-IOC Network on Neuroimmunomodulation (IOC/Fiocruz) - (WS Grant: IOC-006-FIO-24).